| Product Name | MF | CAS | Details |
|---|
| 2-(4-METHOXYPHENYLUREIDO)ACETIC N2-(N-(2,5-DIMETHOXYPHENYL)CARBAMOYL)HYDRAZIDE | C19H23N5O6 | 200629-98-7 | Details |
| 9-BR-5-(2-CHLORO-PH)-2-(4-F-PH)-1,10B-DIHYDROPYRAZOLO(1,5-C)(1,3)BENZOXAZINE | C22H15BrClFN2O | 883812-91-7 | Details |
| PrEST Antigen LYSMD3 | Details |
| RCL T228621 | 102284-24-2 | Details |
| Housing 10", inline, C-7, single cartr | Details |
| 3-Bromo-5-ethoxy-4-methoxybenzaldehyde | C10H11BrO3 | 81805-97-2 | Details |
| BL21(DE3) Competent Cells - Novagen | Details |
| 9-(1H-IMIDAZOL-5-YL)-3,3,6,6-TETRAMETHYL-3,4,6,7,9,10-HEXAHYDRO-1,8(2H,5H)-ACRIDINEDIONE | C20H25N3O2 | 883822-87-5 | Details |
| 4-(2-ACETYLCARBOHYDRAZONOYL)PHENYL 3-CHLOROBENZOATE | C16H13ClN2O3 | 879200-57-4 | Details |
| 2-[(3Z)-3-(3-CYCLOHEXYL-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE)-2-OXO-2,3-DIHYDRO-1H-INDOL-1-YL]-N-(4-FLUOROPHENYL)ACETAMIDE | C25H22FN3O3S2 | 381205-17-0 | Details |
| PrEST Antigen B4GALT7 | Details |
| Anti-TMEM218 antibody produced in rabbit | Details |
| Anti-FNIP1 Antibody, clone 1C10.2 | Details |
| 4-(2-((2-CHLOROANILINO)(OXO)ACETYL)CARBOHYDRAZONOYL)PHENYL 2-BROMOBENZOATE | C22H15BrClN3O4 | 767288-42-6 | Details |
| Anti-CCDC44 antibody produced in mouse | Details |
| N'-(4-HO-BENZYLIDENE)-3-(4-((4-METHYLBENZYL)OXY)PH)-1H-PYRAZOLE-5-CARBOHYDRAZIDE | C25H22N4O3 | 1285682-64-5 | Details |
| 5-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-1-propyl-1H-pyrazole | C11H19BN2O2 | 1487355-92-9 | Details |
| Anti-Stat3b Antibody, clone 516 G10H9 | Details |
| 1-BENZYL-4-(4-BROMO-BENZYLIDENE-HYDRAZINOCARBONYL)-PYRIDINIUM, CHLORIDE | 467444-59-3 | Details |
| N-(3,4-DIMETHYLPHENYL)-2-((4,6-DIMETHYL-2-PYRIMIDINYL)SULFANYL)ACETAMIDE | C16H19N3OS | 332018-41-4 | Details |
| 3-METHYL-2-[(3-METHYL-5,7-DIPHENYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-3-IUM-2-YL)METHYL]-5,7-DIPHENYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-3-IUM BIS(4-METHYLBENZENESULFONATE) | 81430-60-6 | Details |
| TRIMETHYL-PHENYL-AMMONIUM, IODIDE | C9H14IN | 98-04-4 | Details |
| N-ETHYLACETOACETANILIDE | C12H15NO2 | 91640-35-6 | Details |
| endo-Bicyclo[2.2.2]oct-5-ene-2,3-dicarboxylic anhydride | C10H10O3 | 24327-08-0 | Details |
| 1,1-DIMETHYL-3-(2,2,2-TRICHLORO-1-P-TOLYLAMINO-ETHYL)-UREA | 300799-89-7 | Details |
| Anti-MYH9 antibody produced in rabbit | Details |
| 4-BROMO-2-{(E)-[(4-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOYL)HYDRAZONO]METHYL}PHENYL (2E)-3-PHENYL-2-PROPENOATE | C29H21BrClN3O5S | 477732-77-7 | Details |
| Anti-Cytokeratin 10 (CK-10) antibody, Rabbit monoclonal | Details |
| 5-ADAMANTAN-1-YL-2H-PYRAZOLE-3-CARBOXYLIC ACID (4-METHYL-BENZYLIDENE)-HYDRAZIDE | C22H26N4O | 307320-58-7 | Details |
| Anti-PRKAR1A antibody produced in mouse | Details |
| Silver acetylacetonate | C5H7AgO2 | 15525-64-1 | Details |
| 4-isothiocyanato-N,N-dimethylaniline | C9H10N2S | 2131-64-8 | Details |
| RCL T199796 | Details |
| Monoclonal Anti-AP-2α antibody produced in mouse | Details |
| 2,4-Difluorobenzoyl chloride | C7H3ClF2O | 72482-64-5 | Details |
| ET 3-(2-METHYLPHENYL)-7-(4-NITROBENZOYL)PYRROLO(1,2-C)PYRIMIDINE-5-CARBOXYLATE | C24H19N3O5 | 374636-60-9 | Details |
| 1-(4-BROMOANILINO)-2-ISOPENTYL-3-METHYLPYRIDO(1,2-A)BENZIMIDAZOLE-4-CARBONITRILE | C24H23BrN4 | 385419-06-7 | Details |
| FURFURYL N-(4-METHYL-2-NITROPHENYL)CARBAMATE | C13H12N2O5 | 199443-23-7 | Details |
| Anti-Uncoupling Protein 1 Antibody | Details |
| Tripod quick change adapter | Details |
| N-(3-CHLORO-4-METHYLPHENYL)-2-(2-ISOPROPYL-5-METHYLPHENOXY)ACETAMIDE | C19H22ClNO2 | 304893-44-5 | Details |
| Anti-Monomethyl-Histone H3 (Lys4) antibody, Rabbit monoclonal | Details |
| N'-(4-(DIMETHYLAMINO)BENZYLIDENE)-3-(2-THIENYL)-1H-PYRAZOLE-5-CARBOHYDRAZIDE | C17H17N5OS | 307323-29-1 | Details |
| Universal Rapid Battery Charger, 120 V (US) | Details |
| Anti-KAT1/HAT1 antibody produced in rabbit | Details |
| 5-(4-METHYLPHENYL)-4-((2-PYRIDINYLMETHYLENE)AMINO)-4H-1,2,4-TRIAZOLE-3-THIOL | C15H13N5S | 489465-48-7 | Details |
| 2,4-BIS-(2-(4-DIMETHYLAMINO-PHENYL)-VINYL)-7-METHYL-CHROMENYLIUM, PERCHLORATE | 201416-51-5 | Details |
| KDS Legato 210P series syringe pump, infuse/withdraw, programmable | Details |
| 1,5,9,13-Tetrathiacyclohexadecane | C12H24S4 | 295-91-0 | Details |
| 2-(ALLYLOXY)-5-BROMOBENZALDEHYDE N-(4-METHOXYPHENYL)THIOSEMICARBAZONE | C18H18BrN3O2S | 880038-76-6 | Details |
| 6-Bromo-2-chloro-3-(3-chloropropyl)quinoline | C12H10BrCl2N | 612494-85-6 | Details |
| 2-METHYL-3-(4-NITROPHENYL)-4-OXO-4H-CHROMEN-7-YL 2-[(TERT-BUTOXYCARBONYL)AMINO]-3-METHYLPENTANOATE | C27H30N2O8 | 1396986-56-3 | Details |
| 2-[(1R)-1-Aminoethyl]-phenol | C8H11NO | Details |
| 4,4-DIMETHYL-2-OXO-5-ALPHA-ANDROSTAN-3-BETA-YL ACETATE | Details |
| 8-QUINOLINYL N-(3-BROMOPHENYL)CARBAMATE | C16H11BrN2O2 | 14628-12-7 | Details |
| NAPHTHALENE-2-SULFONIC ACID O-TOLYLAMIDE | C17H15NO2S | 63295-54-5 | Details |
| TERT-BUTYL(DIMETHYL)[(4-METHYL-4-PENTENYL)OXY]SILANE | C12H26OSi | 871840-51-6 | Details |
| 1-ETHYL-4-HO-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID N'-OCTANOYL-HYDRAZIDE | C20H27N3O4 | 300839-49-0 | Details |
| 5,7-Dichloro-2-methylquinoline | C10H7Cl2N | 26933-09-5 | Details |
| 6-Methyl-2-[(3-piperidinylmethyl)amino]-4-pyrimidinol | C11H18N4O | 1239758-87-2 | Details |
| 3-AMINO-4-METHOXYBENZANILIDE | C14H14N2O2 | 120-35-4 | Details |
| Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate | C6H7ClN4O2 | 1458-01-1 | Details |
| Furamidine dihydrochloride | C18H16N4O | 55368-40-6 | Details |
| N-[2-(2-ethoxyphenoxy)ethyl]-2-methyl-1-propanamine hydrochloride | Details |
| Mefexamide hydrochloride | C15H24N2O3 | 1227-61-8 | Details |
| Anti-SF3b155 (SAP 155) Antibody | Details |
| (3AS,6AS,9AR,10R,10AS)-3-[(BENZYLOXY)METHOXY]-6,10A-DIMETHYL-1,2,3,3A,4,6A,9,9A,10,10A-DECAHYDRODICYCLOPENTA[A,D]CYCLOOCTEN-10-OL | C24H32O3 | 1217498-60-6 | Details |
| Anti-HOXA10 (N-terminal) antibody produced in rabbit | Details |
| TRANS-3-PHENYL-N-(CIS-3-PHENYL-ALLYL)ACRYLAMIDE | 59015-34-8 | Details |
| 2-(2-CHLORO-PHENOXY)-N-(3-CHLORO-PHENYL)-ACETAMIDE | 70907-45-8 | Details |
| 1-Bromo-3-chlorobenzene | C6H4BrCl | 108-37-2 | Details |
| N'(1),N'(4)-BIS[(3Z)-5-BROMO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE]TEREPHTHALOHYDRAZIDE | 331247-89-3 | Details |
| Scienceware? ROTO-FLO? flow indicator | Details |
| furosta-5,20(22)-dien-3,26-diol | C27H42O3 | 1314685-90-9 | Details |
| 3-(3,4-dimethoxyphenyl)-2-hydroxypropanoic acid | C11H14O5 | 32255-79-1 | Details |
| Lithium trimethylsilanolate | C3H9LiOSi | 2004-14-0 | Details |
| Spirapril for system suitability | Details |
| 4-(2-(((3,4-DIMETHOXYBENZOYL)AMINO)ACETYL)CARBOHYDRAZONOYL)PHENYL 1-NAPHTHOATE | C29H25N3O6 | 767313-91-7 | Details |
| Ethyl 2-(2-methoxyphenoxy)-2-methylpropanoate | C13H18O4 | 211177-72-9 | Details |
| 2,6-DIMETHYL-2-CHROMEN-4-ONE | C11H10O2 | 16108-51-3 | Details |
| N-(2,5-DI-CL-PH)-2-((1,2,4)TRIAZOLO(3,4-B)(1,3)BENZOTHIAZOL-3-YLTHIO)ACETAMIDE | C16H10Cl2N4OS2 | 314260-63-4 | Details |
| 7-ISOPENTYL-3-METHYL-8-((2-PHENYLETHYL)AMINO)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE | C19H25N5O2 | 378205-98-2 | Details |
| 3-(BENZYLAMINO)-2-OXO-2,5,6,7-TETRAHYDRO-1H-AZEPINE-4-CARBONITRILE | C14H15N3O | 329003-14-7 | Details |
| 5-Bromobenzoxazole-2-thiol | C7H4BrNOS | 439607-87-1 | Details |
| 1-(4-BROMOPHENYL)-3-({4-[(4-{[3-(4-BROMOPHENYL)-3-OXOPROPYL]SULFANYL}PHENYL)SULFANYL]PHENYL}SULFANYL)-1-PROPANONE | C30H24Br2O2S3 | 882748-83-6 | Details |
| 3-[(Z)-(3-BENZYL-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-[(2-PHENYLETHYL)AMINO]-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE | C27H22N4O2S2 | 431934-37-1 | Details |
| PAMAQUINE NAPHTHOATE | C42H45N3O7 | 635-05-2 | Details |
| N-[1,1'-BIPHENYL]-2-YL-2-{[3-(4-METHYLPHENYL)-4-OXO-3,4,5,6,7,8-HEXAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-2-YL]SULFANYL}ACETAMIDE | C31H27N3O2S2 | 460996-60-5 | Details |
| 7-Ketodeoxycholic acid | C24H38O5 | 911-40-0 | Details |
| ETHYL 4-{2,5-DIMETHYL-3-[([1,2,4]TRIAZOLO[3,4-B][1,3]BENZOTHIAZOL-3-YLSULFANYL)ACETYL]-1H-PYRROL-1-YL}BENZOATE | C25H22N4O3S2 | 379248-43-8 | Details |
| 3-[(Z)-(3-BUTYL-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-9-METHYL-2-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE | C22H26N4O3S2 | 381179-22-2 | Details |
| Anti-CGB3 antibody produced in rabbit | Details |
| ALPHA-(4-HYDROXYPHENYLIMINO)-P-CRESOL | C13H11NO2 | 3246-65-9 | Details |
| Anti-AS160 (Rab-GAP) Antibody | Details |
| Anti-RGS4 Antibody | Details |
| NICOTINIC ACID (2-HYDROXY-BENZYLIDENE)-HYDRAZIDE | C13H11N3O2 | 15017-28-4 | Details |
| ME ((7-HEXYL-1,3-DI-ME-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL)THIO)ACETATE | C16H24N4O4S | 371134-02-0 | Details |
| Citalopram Related Compound B | C22H23FN2O6 | 1332724-03-4 | Details |
| Reducer | Details |
| 8-[(2-FURYLMETHYL)AMINO]-7-(2-HYDROXY-3-ISOPROPOXYPROPYL)-3-METHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE | C17H23N5O5 | 333752-28-6 | Details |
| Product Total： Product Page： | ||||
| 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 | ||||